Columbia-Presbyterian Medical Center

New York, New York 11032

0 studies enrolling now · 59 studies all time

What they study most

Acute Ischemic Stroke, Acute Lymphoblastic Leukemia, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Androgen Independent Prostate Cancer (AIPC), Anemia, Arterial Occlusive Diseases, Asthma, Autoimmune Diseases, Blepharospasm, Breast Cancer, Carcinoma, Renal Cell

Studies at this site

• Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique — Running, not enrolling
• Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) — Completed
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes — Completed
• Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer — Stopped early
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed
• A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy — Completed
• A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer — Completed
• TroVax Renal Immunotherapy Survival Trial — Completed
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. — Completed
• Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma — Completed
• Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm — Completed
• Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity — Completed
• Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders — Stopped early
• Medical Therapy of Prostatic Symptoms — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure — Stopped early
• Low-Dose Leptin and the Formerly-Obese — Status unconfirmed
• Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD) — Completed
• Heartsbreath Test for Heart Transplant Rejection — Status unconfirmed
• High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis — Completed
• Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer — Completed
• Clinical Trials of Two Non-drug Treatments for Chronic Depression — Completed
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed
• Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. — Completed
• Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects — Completed
• FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) — Withdrawn before enrolling
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders — Stopped early
• Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) — Stopped early
• The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices — Stopped early
• The Epidemiology of Ventricular Assist Device-Related Infections — Completed
• CP-461 in the Treatment of Patients With Advanced Melanoma — Stopped early
• Study Using CP-461 to Treat Advanced Prostate Cancer — Completed
• Parkinson's Research: The Organized Genetics Initiative — Completed
• Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy — Completed
• Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations — Completed
• Islet Transplantation for Patients With Type 1 Diabetes — Completed
• Estrogen Hormone Protocol — Completed
• ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere — Status unconfirmed
• Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children — Completed
• Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke — Stopped early
• PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients — Completed
• Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery — Completed
• MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer — Completed
• Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome — Status unconfirmed
• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease — Completed